Humana has better odds than CVS Health of acquiring Cano Health because the insurer already has a right-of-refusal agreement with the company and a huge position in the Medicare Advantage market, Becker’s reports, citing market researcher Insider Intelligence.
CVS Health and Humana are among the potential buyers for Cano Health, a tech-driven primary care disruptor, Bloomberg and The Wall Street Journal reported recently. Humana has the right-of-refusal arrangement in the event of a sale as part of a 2019 agreement with Cano, the Journal reported.
Whoever wins the bidding war will gain a strong foothold in senior primary care, as about 44 percent of Cano Health’s patients are on Medicare Advantage, a value-based care program for seniors, Insider Intelligence reported. Humana is already second in the Medicare Advantage market behind UnitedHealthcare. Read more.